Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > PTCT PTC Therapeutics > Detailed Quotes

PTCT PTC Therapeutics

Watchlist
39.750
+0.350+0.89%
Close 11/25 13:00 ET
39.7500.0000.00%
Post Mkt Price 11/25 13:00 ET
High
40.480
Open
39.300
Turnover
9.41M
Low
39.030
Pre Close
39.400
Volume
235.99K
Market Cap
2.86B
P/E(TTM)
Loss
52wk High
55.580
Shares
71.88M
P/E(Static)
Loss
52wk Low
25.010
Float Cap
2.56B
Bid/Ask %
33.33%
Historical High
78.720
Shs Float
64.45M
Volume Ratio
0.83
Historical Low
4.030
Dividend TTM
--
Div Yield TTM
--
P/B
-12.59
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.37%
Amplitude
3.68%
Avg Price
39.859
Lot Size
1
Float Cap
2.56B
Bid/Ask %
33.33%
Historical High
78.720
Shs Float
64.45M
Volume Ratio
0.83
Historical Low
4.030
Dividend TTM
--
P/B
-12.59
Dividend LFY
--
Turnover Ratio
0.37%
Amplitude
3.68%
Avg Price
39.859
Lot Size
1
Price Forecast

No Data

News

Comment

Sign in to post a comment

No comment yet

Company Overview More
PTC Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and commercialization of clinically differentiated medicines. It focuses on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. The firm's portfolio includes Translarna, Emflaza, Tegsedi, Waylivra, and Evrysdi. The company was founded by Allan Steven Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.
CEO: Dr. Stuart W. Peltz, PhD
Market: NASDAQ
Listing Date: 06/20/2013
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist